Menu

INmune Bio Inc. INMB

Full chart Compare
Set alert

Price alert · INMB

All alert types
1.13 USD -0.05 (-3.83%)

At closeNov 6, 2026, 7:58 PM EST

1.03 -0.10 -8.97%

After hours · Nov 6, 7:58 PM ET

1.06 Day range 1.26
1.12 52-week range 2.51
YTD
-27.56%
1 year
-30.67%

Revenue & Expenses

Other Income → Expenses: $1.45MExpenses → Selling, General & Admin: $10.26MExpenses → Research & Development: $20.66MExpenses → Other Operating Expenses: $16.51MGross Profit → Expenses: $50.00KRevenue → Gross Profit: $50.00KNet Loss → Expenses: $45.93MOther Income$1.45MGross Profit$50.00KNet Loss$45.93MExpenses$47.43MSelling, General & Admin$10.26MResearch & Development$20.66MOther Operating Expenses$16.51MRevenue$50.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

INMB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
50.00K14.00K155.00K374.00K181.00K
50.00K14.00K155.00K374.00K181.00K
-47.38M-42.63M-29.74M-27.30M-30.34M
-45.93M-42.08M-30.01M-27.30M-30.34M
-1.86-2.11-1.67-1.52-1.88
INMB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
24.75M20.92M35.85M52.15M74.81M
32.35M39.56M57.00M81.80M99.94M
8.83M7.46M18.86M21.69M19.72M
1.03M384.00K10.44M15.31M15.23M
23.52M32.10M37.34M60.10M80.22M
INMB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-22.58M-33.36M-11.98M-22.69M-28.50M
-1.04M000-15.00M
27.61M18.21M-4.22M729.00K96.36M
-1.04M0000
3.83M-14.93M-16.30M-22.66M52.84M